Clinical Trials Browser

INDUSTRY × RNA-Seq × Breast × Clear all

NCT03521245 2021-09-14

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Breast Neoplasms